Apr 12, 2022 / 03:45PM GMT
Serge Belanger - Needham & Company, LLC - Analyst
Hi, good morning. Welcome to Needham's 21st annual healthcare conference. I'm Serge Belanger, one of the healthcare analysts at Needham. We're happy to have, for our next session, OptiNose. And we have the Company's CEO, Peter Miller with us; as well as the CFO, Keith Goldan; and the Chief Operating Officer, Ramy Mahmoud. So I'll hand it over to Peter to go through the presentation. (Operator Instructions)
So let me hand it over to Peter.
Peter Miller - Optinose, Inc. - CEO
Serge, thanks very much. We're very, very excited to be here, and thanks for having us. So I'm going to begin, and I'd like to remind everyone -- if you go to the next slide, Keith -- that we will be making forward-looking statements today. I encourage you to look at our SEC filing regarding those statements.
So this is what we believe a very exciting time for our company. The past several years, we've been building a business in the ENT allergy segment and have a very exciting near-term expansion opportunity that we're
OptiNose Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers